Pharmaceutical Manufacturer Implements Cost-Effective
Cure for Batch and Sequence Management
with Rockwell Automation

AMPAC Fine Chemicals is known for its leading-edge capabilities utilizing potentially
hazardous, energetic chemistries for the production of high-potency APIs.

Background

When afflicted with a headache, stomachache or ache of any kind,
taking medicine can often mean the difference between a productive
day and miserable hours stuck in bed. While medications are often
an easy fix to common ailments, those pills would be fairly useless
without the active pharmaceutical ingredients (APIs) manufactured by
companies like AMPAC Fine Chemicals (AFC), a subsidiary of American
Pacific Corporation. AFC works with leading pharmaceutical companies
to research, develop and manufacture the APIs found in many leading
prescription medications that help save lives – and cure our aches.
Based in Rancho Cordova, Calif., AFCs’ manufacturing facilities are
designed to meet a wide range of needs. The company typically manages
up to 15 development projects at any given time, producing small
quantities of APIs for process expansion and trial testing of new drugs.
As those drugs are tested and approved, AFC moves the manufacturing
process to a semiwork scale facility. Here, engineers and product
development experts can cost-effectively correct process kinks to reduce
waste and increase throughput before full-scale production begins.
In fact, the company typically runs multiple full, commercial-scale
products simultaneously, generating multiton quantities of APIs that
are shipped in bulk to pharmaceutical companies around the globe.
These pharmaceutical companies then incorporate the APIs into
digestible form

Click here to read the full article →